Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robby Nieuwlaat

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 26, 2011
The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation researchRobby Nieuwlaat
Heart (British Cardiac Society)|October 28, 2008
Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomesRobby Nieuwlaat, Stuart J Connolly
Annals of Internal Medicine|August 18, 2010
ACP Journal Club. Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AFRobby Nieuwlaat, Stuart J Connolly
JAMA Internal Medicine|February 3, 2016
Mobile Text Messaging and Adherence of Patients to Medication Prescriptions: A txt a dA keeps da doctR awA?Robby Nieuwlaat, Niraj Mistry, R Brian Haynes
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2020
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillationMiney Paquette, Lawrence Mbuagbaw, Alfonso Iorio, et al.
Contemporary Clinical Trials Communications|April 24, 2019
Ethical issues in competing clinical trialsMiney Paquette, Julija Kelecevic, Lisa Schwartz, et al.
European Heart Journal|February 5, 2013
Why are we failing to implement effective therapies in cardiovascular disease?Robby Nieuwlaat, Jon-David Schwalm, Rasha Khatib, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 29, 2010
Factors determining utility measured with the EQ-5D in patients with atrial fibrillationJenny Berg, Peter Lindgren, Robby Nieuwlaat, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2009
Comprehensive upstream treatment for atrial fibrillation, when and how?Ron Pisters, Robby Nieuwlaat, Cees B de Vos, et al.
Systematic Reviews|October 27, 2019
A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillationMiney Paquette, Ahlam Mohammed Alotaibi, Robby Nieuwlaat, et al.
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 26, 2011
The value of cardiovascular hospitalization as an endpoint for clinical atrial fibrillation researchRobby Nieuwlaat
Heart (British Cardiac Society)|October 28, 2008
Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomesRobby Nieuwlaat, Stuart J Connolly
Annals of Internal Medicine|August 18, 2010
ACP Journal Club. Lenient rate control is as effective as strict rate control for preventing cardiovascular events in AFRobby Nieuwlaat, Stuart J Connolly
JAMA Internal Medicine|February 3, 2016
Mobile Text Messaging and Adherence of Patients to Medication Prescriptions: A txt a dA keeps da doctR awA?Robby Nieuwlaat, Niraj Mistry, R Brian Haynes
European Heart Journal. Cardiovascular Pharmacotherapy|May 20, 2020
Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillationMiney Paquette, Lawrence Mbuagbaw, Alfonso Iorio, et al.
Contemporary Clinical Trials Communications|April 24, 2019
Ethical issues in competing clinical trialsMiney Paquette, Julija Kelecevic, Lisa Schwartz, et al.
European Heart Journal|February 5, 2013
Why are we failing to implement effective therapies in cardiovascular disease?Robby Nieuwlaat, Jon-David Schwalm, Rasha Khatib, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 29, 2010
Factors determining utility measured with the EQ-5D in patients with atrial fibrillationJenny Berg, Peter Lindgren, Robby Nieuwlaat, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 25, 2009
Comprehensive upstream treatment for atrial fibrillation, when and how?Ron Pisters, Robby Nieuwlaat, Cees B de Vos, et al.
Systematic Reviews|October 27, 2019
A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillationMiney Paquette, Ahlam Mohammed Alotaibi, Robby Nieuwlaat, et al.
Pageof 14